Accuracy of FENO for diagnosing asthma: a systematic review
S Karrasch, K Linde, G Rücker, H Sommer… - Thorax, 2017 - thorax.bmj.com
Background Measurement of FENO might substitute bronchial provocation for diagnosing
asthma. We aimed to investigate the diagnostic accuracy of FENO measurement compared …
asthma. We aimed to investigate the diagnostic accuracy of FENO measurement compared …
European Respiratory Society guidelines for the diagnosis of asthma in adults
Although asthma is very common, affecting 5–10% of the population, the diagnosis of
asthma in adults remains a challenge in the real world, which results in both over-and under …
asthma in adults remains a challenge in the real world, which results in both over-and under …
Inhaled corticosteroid therapy in adult asthma. Time for a new therapeutic dose terminology
The Global Initiative for Asthma guidelines use the traditional terminology of “low,”“medium,”
and “high” doses of inhaled corticosteroids (ICS) to define daily maintenance doses of 100 …
and “high” doses of inhaled corticosteroids (ICS) to define daily maintenance doses of 100 …
Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator …
DB Price, R Buhl, A Chan, D Freeman… - The Lancet …, 2018 - thelancet.com
Background Chronic non-specific respiratory symptoms are difficult to manage. This trial
aimed to evaluate the association between baseline fractional exhaled nitric oxide (FeNO) …
aimed to evaluate the association between baseline fractional exhaled nitric oxide (FeNO) …
Severe T2-high asthma in the biologics era: European experts' opinion
The European Respiratory Biologics Forum gathered participants from 21 countries in
Madrid, Spain, to discuss the management and treatment of severe asthma in the era of …
Madrid, Spain, to discuss the management and treatment of severe asthma in the era of …
Fractional exhaled nitric oxide and asthma treatment adherence
CA Butler, LG Heaney - Current opinion in allergy and clinical …, 2021 - journals.lww.com
Assessment of adherence and FeNO response to monitored inhaled corticosteroid in Type-2
biomarker high asthmatic individuals may prevent unnecessary escalation to biologic …
biomarker high asthmatic individuals may prevent unnecessary escalation to biologic …
Diagnostic accuracy of FeNO in asthma and predictive value for inhaled corticosteroid responsiveness: A prospective, multicentre study
A Schneider, B Brunn, A Hapfelmeier, K Schultz… - …, 2022 - thelancet.com
Background Fractional exhaled nitric oxide (FeNO) is promising for diagnosing asthma and
could replace bronchial provocation (BP). To date, cut-off values have been derived by post …
could replace bronchial provocation (BP). To date, cut-off values have been derived by post …
Type 2 biomarkers and prediction of future exacerbations and lung function decline in adult asthma
R Semprini, M Williams, A Semprini, A McDouall… - The Journal of Allergy …, 2018 - Elsevier
Background Type 2 biomarkers that predict both likelihood of future severe exacerbations
and response to mAb therapy in asthma would be useful clinically in identifying patients both …
and response to mAb therapy in asthma would be useful clinically in identifying patients both …
Treatable traits of chronic airways disease
J Fingleton, J Hardy, R Beasley - Current opinion in pulmonary …, 2018 - journals.lww.com
Current evidence suggests that the precision medicine approach based on the identification
and treatment of treatable traits is preferable to a 'one-size-fits-all'stepwise approach to the …
and treatment of treatable traits is preferable to a 'one-size-fits-all'stepwise approach to the …